Express Scripts adds Harvoni, expands indication-based pricing

Among a handful of changes revealed Monday, Express Scripts Holding Co. (NASDAQ:ESRX) said it will expand the formulary of its Hepatitis Cure Value Program

Read the full 243 word article

User Sign In